Clinical Trial

Mebendazole as Adjuvant Treatment for Colon Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
mebendazole treating colon cancer
Trial Details
NCT Number NCT03925662
Lead Sponsor Sherief Abd-Elsalam
Conditions Colorectal Cancer
Enrollment 40 participants
Start Date 2019-04-01
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2019-04-24